Whiteside to head global FX at Lehman

Lehman Brothers has brought in its fixed-income liquid markets sales head, Grant Whiteside, to head global FX. Currently based in New York, Whiteside will move to London for the role later this year, a bank spokesman said.

Former global head of foreign exchange, New York-based Mark De Gennaro, now becomes head of global FX sales, reporting to Whiteside. De Gennaro had only recently re-assumed full responsibility for Lehman’s global foreign exchange business after London-based co-head Ivan Ritossa left the bank to join Barclays Capital.

A spokesman for Lehman Brothers in New York said the move was part of an ongoing expansion of the bank’s activities for institutional clients in FX markets globally. "We’ve focused on a number of different businesses in capital markets, and we’re now looking to upgrade FX," he said. In his former role, Whiteside, who has worked for Lehman Brothers for 18 years, had significant involvement in foreign exchange, and knows the business well, the spokesman added.

The spokesman denied that Whiteside’s appointment represented a demotion for De Gennaro. "The business itself has grown with the greater commitment to building up the FX product line, so there has been an overall increase in the size of role he has," he said.

De Gennaro will initially transfer to London to manage the overall business side of FX in the City until Whiteside can relocate from New York, said the spokesman. Thereafter, De Gennaro will return to New York, and Whiteside will continue to spend a significant amount of time in New York according to client needs, the spokesman added.

Meanwhile, Lehman Brothers also confirmed the hire of a senior dealer in FX sales. Karenna Kwok starts at the bank today, focusing on North American clients. She leaves State Street in Boston, where she was a vice-president in FX sales.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here